tetano
Editor, Senior Moderator
Pathogens
. 2020 Dec 8;9(12):E1027.
doi: 10.3390/pathogens9121027.
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
Nima Taefehshokr[SUP] 1 [/SUP], Sina Taefehshokr[SUP] 2 [/SUP], Bryan Heit[SUP] 1 3 [/SUP]
Affiliations
Abstract
The current coronavirus disease 2019 (COVID-19) pandemic, a disease caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), was first identified in December 2019 in China, and has led to thousands of mortalities globally each day. While the innate immune response serves as the first line of defense, viral clearance requires activation of adaptive immunity, which employs B and T cells to provide sanitizing immunity. SARS-CoV-2 has a potent arsenal of mechanisms used to counter this adaptive immune response through processes, such as T cells depletion and T cell exhaustion. These phenomena are most often observed in severe SARS-CoV-2 patients, pointing towards a link between T cell function and disease severity. Moreover, neutralizing antibody titers and memory B cell responses may be short lived in many SARS-CoV-2 patients, potentially exposing these patients to re-infection. In this review, we discuss our current understanding of B and T cells immune responses and activity in SARS-CoV-2 pathogenesis.
Keywords: B and T cell immune response; COVID-19; SARS-CoV-2; adaptive immunity.
. 2020 Dec 8;9(12):E1027.
doi: 10.3390/pathogens9121027.
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
Nima Taefehshokr[SUP] 1 [/SUP], Sina Taefehshokr[SUP] 2 [/SUP], Bryan Heit[SUP] 1 3 [/SUP]
Affiliations
- PMID: 33302366
- DOI: 10.3390/pathogens9121027
Abstract
The current coronavirus disease 2019 (COVID-19) pandemic, a disease caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), was first identified in December 2019 in China, and has led to thousands of mortalities globally each day. While the innate immune response serves as the first line of defense, viral clearance requires activation of adaptive immunity, which employs B and T cells to provide sanitizing immunity. SARS-CoV-2 has a potent arsenal of mechanisms used to counter this adaptive immune response through processes, such as T cells depletion and T cell exhaustion. These phenomena are most often observed in severe SARS-CoV-2 patients, pointing towards a link between T cell function and disease severity. Moreover, neutralizing antibody titers and memory B cell responses may be short lived in many SARS-CoV-2 patients, potentially exposing these patients to re-infection. In this review, we discuss our current understanding of B and T cells immune responses and activity in SARS-CoV-2 pathogenesis.
Keywords: B and T cell immune response; COVID-19; SARS-CoV-2; adaptive immunity.